Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Zhongxing BioTech(002772) the Revenue is 483.38 M (+11.07%);the EBIT is 38.4 M (+276.5%);the EPS is 0.0738 (+32.78%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.48B11.07%
----
----
EBIT
0.04B276.53%
----
----
EPS
0.073832.78%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf